Research Insights
Canadian-Led HBOT Research: What the Literature Shows
246 of 14,630 indexed studies (1.7%) are led by Canadian researchers or institutions.
A study counts as Canadian-led when its author affiliations name a Canadian institution. The national share matters because Canadian trials reflect Canadian practice patterns, provincial coverage rules, and patient populations, which makes their findings the most directly applicable to care decisions made here.
246
Canadian-led studies
1.7%
of the indexed corpus
This reflects research production, not clinical endorsement. Canadian-led status is determined by the country of affiliation of a study's first or last author. The presence (or absence) of Canadian-authored studies on a topic does not indicate that HBOT is approved, funded, or recommended for that use in Canada. For what is covered, see the conditions and coverage pages.
Canadian-led studies indexed per year, 2010-2025
Each row: Canadian-led studies / all indexed studies that year.
Data generated September 4, 2026; updated weekly. How this data is produced.